CXCL1 and prostate carcinoma: Emerging evidence confirms that chemokines, including chemokine (C-X-C motif) ligand 1 (CXCL1), enhance cell proliferation and invasion in high-grade prostate cancer, gastric cancer, and other cancers [15,16].